Sernova (TSE:SVA) Stock Price Down 9.1% – Here’s What Happened

Sernova Corp. (TSE:SVA)’s stock price was down 9.1% on Monday . The company traded as low as C$0.10 and last traded at C$0.10. 202,103 shares were traded during mid-day trading, an increase of 69% from the average daily volume of 119,336 shares. The stock had previously closed at C$0.11.

Sernova Stock Performance

The firm has a market cap of C$37.76 million, a price-to-earnings ratio of -2.50 and a beta of -0.46. The company has a current ratio of 0.14, a quick ratio of 18.11 and a debt-to-equity ratio of -25.45. The stock has a fifty day moving average price of C$0.13 and a 200 day moving average price of C$0.15.

Sernova (TSE:SVA) last issued its quarterly earnings data on Thursday, June 11th. The company reported C$0.01 earnings per share for the quarter. As a group, analysts predict that Sernova Corp. will post -0.08 earnings per share for the current year.

Sernova Company Profile

Sernova Biotherapeutics is a clinical-stage company developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem-cell derived islet-like clusters in collaboration with Evotec to create bio-hybrid organs to treat T1D. A bio-hybrid organ is comprised of non-biomaterials, such as the Cell Pouch, integrated with living tissues to restore or enhance the function of a compromised organ. This innovative approach aims to deliver a potentially revolutionary treatment for patients with chronic diseases, initially focusing on T1D and thyroid disorders.